TAS-102 (Lonsurf) is an oral cytotoxic drug that has a nucleoside analog (trifluridine) and a thymidine phosphorylase inhibitor (tipiracil) approved for use in refractory metastatic colorectal cancer. The gene discussed is TYMP; the disease is metastatic colorectal cancer.